Dr.ย Sook Ryunย Park
MD, MM, PhD
Professor, Department of Oncology
corporate_fareAsan Medical Center, Seoul, South Korea
Sook Ryun Park
MD, MM, PhD
Prof. Sook Ryun Park is a Professor in the Department of Oncology at Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. She specialises in medical oncology for gastrointestinal cancers, with a particular clinical and research focus on gastric cancer, esophageal cancer, liver cancer, and gastrointestinal stromal tumour.
Prof. Park completed her MD, Master of Medicine, and PhD at Seoul National University College of Medicine, followed by internship, residency, and fellowship at Seoul National University Hospital before joining the oncology faculty at Asan Medical Center, where she has served as Clinical Assistant Professor, Associate Professor, and Professor since 2013. Her official hospital profile places her across multiple specialist centres including the AMC Cancer Institute, Liver Center, Liver Cancer Center, and Esophageal Cancer Center, supporting a multidisciplinary approach to complex gastrointestinal malignancies. Her research spans gastric cancer chemotherapy, immunotherapy-related adverse-event prediction, biomarker analysis, and microbiome-based strategies for overcoming immunotherapy resistance. A multi-institutional study she led resulted in a prediction model for immune-related adverse events before cancer immunotherapy, with findings published in Nature Cancer.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an opinion from Prof. Park, subject to hospital availability and case acceptance.
Why Consider Prof. Sook Ryun Park?
Prof. Park brings over two decades of specialised experience in gastrointestinal oncology at one of South Korea's leading tertiary cancer centres. Her expertise spans systemic treatment, advanced research, and multidisciplinary care for upper GI and liver cancers.
Areas of Specialisation
Focused expertise in gastric, esophageal, liver, and gastrointestinal stromal tumour oncology
Prof. Park's practice at Asan Medical Center covers the full spectrum of gastrointestinal medical oncology, with particular depth in gastric and upper GI malignancies, supported by an active research programme in immunotherapy and biomarker-guided treatment.
Gastric & Esophageal Cancer
Systemic treatment and clinical research in stomach and esophageal cancers, including advanced and metastatic disease.
- arrow_rightChemotherapy for advanced and metastatic gastric cancer
- arrow_rightPerioperative chemotherapy for locally advanced gastric cancer
- arrow_rightTreatment sequencing and response monitoring
- arrow_rightClinical trial-based treatment options where eligible
- arrow_rightSystemic therapy for esophageal and esophagogastric junction cancers
- arrow_rightMultidisciplinary coordination within the Asan Esophageal Cancer Center
- arrow_rightBiomarker analysis to guide treatment selection
Liver Cancer & Gastrointestinal Stromal Tumour
Medical oncology for hepatocellular carcinoma and gastrointestinal stromal tumour within Asan Medical Center's specialist liver and cancer centres.
- arrow_rightSystemic treatment planning for hepatocellular carcinoma
- arrow_rightCoordination within Asan Liver Cancer Center and Liver Center
- arrow_rightIntegration with hepatobiliary multidisciplinary teams
- arrow_rightTargeted systemic therapy for GIST
- arrow_rightMonitoring and treatment adjustment based on response
Immunotherapy & Biomarker Research
Clinical research in immunotherapy adverse-event prediction, biomarker-driven oncology, and microbiome-related strategies.
- arrow_rightLed development of a multi-institutional adverse-event prediction model
- arrow_rightResearch published in Nature Cancer
- arrow_rightBalancing immunotherapy efficacy with patient safety
- arrow_rightMolecular and biomarker analysis for treatment selection
- arrow_rightIntegration of translational oncology findings in GI cancer care
Procedures & Clinical Services
Systemic treatment, clinical research, and multidisciplinary care for gastrointestinal cancers
As a medical oncologist, Prof. Park's services focus on systemic cancer treatment planning, chemotherapy, immunotherapy evaluation, and biomarker-guided therapy for gastric, esophageal, liver, and GI stromal tumour cases.
Systemic Treatment for GI Cancers
Medical OncologyComprehensive systemic treatment planning and administration for gastrointestinal malignancies.
Immunotherapy Assessment & Monitoring
Targeted TherapyEvaluation of immunotherapy suitability, adverse-event prediction, and safety monitoring based on published research.
Second Opinion & Complex GI Case Review
Second OpinionSpecialist review of complex gastrointestinal oncology cases, including second opinions on treatment plans and pathology.
Multidisciplinary GI Cancer Care
MultidisciplinaryCoordination across Asan Medical Center's Cancer Institute, Liver Cancer Center, Liver Center, and Esophageal Cancer Center.
Research & Publications
Peer-reviewed contributions in gastric cancer, immunotherapy, and gastrointestinal oncology
Prof. Park is an active academic oncologist with a strong publication record. Her major research themes include gastric cancer chemotherapy, perioperative treatment strategies, immunotherapy-related adverse-event prediction, and microbiome approaches for immunotherapy resistance.
A bibliometric profile estimated by third-party indexing sources lists more than 250 papers and an h-index of 40. A full publication list is available on request or via PubMed and Google Scholar.
Education & Training
Prof. Park completed her entire undergraduate and postgraduate medical education at Seoul National University College of Medicine, earning her MD, Master of Medicine, and PhD before undertaking clinical training at Seoul National University Hospital.
Clinical Experience
Prof. Park trained at Seoul National University Hospital before building her academic oncology career at Asan Medical Center, University of Ulsan College of Medicine, where she has progressed from Clinical Assistant Professor to full Professor in the Department of Oncology.
Languages & International
Prof. Park's individual language profile is not separately stated in publicly available sources. Asan Medical Center's International Healthcare Center provides professional language support for international patients.
CancerFax and Asan Medical Center's International Healthcare Center can coordinate professional medical interpreter support for international patients in multiple languages.
Asan Medical Center provides professional language support in English, Chinese, Japanese, Russian, Arabic, and Mongolian through its International Healthcare Center.
How CancerFax Helps You Access Dr. Sook Ryun Park
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Sook Ryun Park's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Sook Ryun Park's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Sook Ryun Park before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Sook Ryun Park's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Sook Ryun Park's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Sook Ryun Park's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Sook Ryun Park
Prof. Park specialises in stomach cancer (gastric cancer), liver cancer (hepatocellular carcinoma), esophageal cancer, and gastrointestinal stromal tumour (GIST), as listed on her official Asan Medical Center profile. She also treats other upper gastrointestinal malignancies within the hospital's multidisciplinary cancer centres.
Prof. Park is based at Asan Medical Center in Seoul, South Korea, and holds a faculty position at the University of Ulsan College of Medicine. She is affiliated with the Department of Oncology, AMC Cancer Institute, Liver Center, Liver Cancer Center, and Esophageal Cancer Center.
Asan Medical Center has a dedicated International Healthcare Center that supports foreign patients with appointment coordination, interpretation, escort services, counselling, and billing assistance. CancerFax can additionally help coordinate medical-report review and case preparation for international patients seeking a consultation with Prof. Park, subject to hospital availability and case acceptance.
You can submit your medical reports through CancerFax. The CancerFax team will review the documents, prepare a structured medical summary, and coordinate the next steps with the hospital, subject to availability. Alternatively, international patients may contact Asan Medical Center directly through its International Healthcare Center.
A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history, and relevant test results. Prof. Park's clinical expertise in gastric cancer, esophageal cancer, and gastrointestinal oncology makes her a relevant specialist for second opinions on systemic treatment planning and treatment sequencing. The final consultation format and availability depend on the hospital's scheduling.
Prof. Park has published research in gastric cancer chemotherapy, perioperative treatment strategies for locally advanced gastric cancer, and immunotherapy-related adverse-event prediction. She led a multi-institutional study that developed a prediction model for immune-related adverse events prior to cancer immunotherapy, with findings published in Nature Cancer. She has also contributed as a co-senior author on research into microbiome-based strategies for overcoming immunotherapy resistance in gastrointestinal cancers.
Connect with Sook Ryun Park Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.